ArticleFrontiers in microbiology2025
Gut bacterium
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Strain ALG19, a predominant culturable bacterium isolated from the larval gut of the emerald ash borer ( Methods: The taxonomic classification of ALG19 was determined through whole-genome sequencing, average nucleotide identity (ANI) analysis, and phylogenetic reconstruction based on single-copy orthologous genes. Functional annotation of carbohydrate-active genes was performed using the COG, KEGG, and CAZy databases. Cellulolytic activity was assessed using a multi-faceted approach. First, carboxymethyl cellulose hydrolysis assays were conducted to evaluate cellulolytic capability. Additionally, filter paper degradation and the utilization of velvet ash phloem cellulose were examined. For these experiments, the strain was cultured in an inorganic salt medium supplemented with the respective cellulose substrates for 60 days. Results: Genomic analyses confirmed that ALG19 belongs to Discussion: These findings demonstrate that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.